Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature

Abstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains...

Full description

Bibliographic Details
Main Authors: Ben Pode-Shakked, Asaf Vivante, Ortal Barel, Shai Padeh, Dina Marek-Yagel, Alvit Veber, Shachar Abudi, Aviva Eliyahu, Irit Tirosh, Shiri Shpilman, Shirlee Shril, Friedhelm Hildebrandt, Mordechai Shohat, Yair Anikster
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Medical Genetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12881-019-0787-x
_version_ 1818320964187848704
author Ben Pode-Shakked
Asaf Vivante
Ortal Barel
Shai Padeh
Dina Marek-Yagel
Alvit Veber
Shachar Abudi
Aviva Eliyahu
Irit Tirosh
Shiri Shpilman
Shirlee Shril
Friedhelm Hildebrandt
Mordechai Shohat
Yair Anikster
author_facet Ben Pode-Shakked
Asaf Vivante
Ortal Barel
Shai Padeh
Dina Marek-Yagel
Alvit Veber
Shachar Abudi
Aviva Eliyahu
Irit Tirosh
Shiri Shpilman
Shirlee Shril
Friedhelm Hildebrandt
Mordechai Shohat
Yair Anikster
author_sort Ben Pode-Shakked
collection DOAJ
description Abstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains challenging. Subsequently, the syndrome is often unrecognized and misdiagnosed (for instance, as Juvenile Idiopathic Arthritis), leading to unnecessary procedures and treatments. The objective of the current study was to identify the molecular basis in a family with PPRD and describe their phenotype and course of illness. Patients and methods We present here a multiply affected consanguineous family of Iraqi-Jewish descent with PPRD. The proband, a 6.5 years old girl, presented with bilateral symmetric bony enlargements of the 1st interphalangeal joints of the hands, without signs of synovitis. Molecular analysis of the family was pursued using Whole Exome Sequencing (WES) and homozygosity mapping. Results WES analysis brought to the identification of a novel homozygous missense mutation (c.257G > T, p.C86F) in the WISP3 gene. Following this diagnosis, an additional 53 years old affected family member was found to harbor the mutation. Two other individuals in the family were reported to have had similar involvement however both had died of unrelated causes. Conclusion The reported family underscores the importance of recognition of this unique skeletal dysplasia by clinicians, and especially by pediatric rheumatologists and orthopedic surgeons.
first_indexed 2024-12-13T10:33:22Z
format Article
id doaj.art-21ee6b5247cf41b39363d1574af2d8da
institution Directory Open Access Journal
issn 1471-2350
language English
last_indexed 2024-12-13T10:33:22Z
publishDate 2019-03-01
publisher BMC
record_format Article
series BMC Medical Genetics
spelling doaj.art-21ee6b5247cf41b39363d1574af2d8da2022-12-21T23:50:47ZengBMCBMC Medical Genetics1471-23502019-03-012011610.1186/s12881-019-0787-xProgressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literatureBen Pode-Shakked0Asaf Vivante1Ortal Barel2Shai Padeh3Dina Marek-Yagel4Alvit Veber5Shachar Abudi6Aviva Eliyahu7Irit Tirosh8Shiri Shpilman9Shirlee Shril10Friedhelm Hildebrandt11Mordechai Shohat12Yair Anikster13Metabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolSheba Cancer Research Center, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterPediatric Rheumatology Unit and Department of Pediatrics, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolDivision of Nephrology, Department of Medicine, Boston Children’s Hospital, Harvard Medical SchoolSheba Cancer Research Center, Sheba Medical CenterMetabolic Disease Unit, Edmond and Lily Safra Children’s Hospital, Sheba Medical CenterAbstract Background Progressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, non-inflammatory arthropathy, shown to be caused by mutations in the WNT1-inducible signaling pathway protein 3 (WISP3) gene. Although several hundred cases were reported worldwide, the diagnosis remains challenging. Subsequently, the syndrome is often unrecognized and misdiagnosed (for instance, as Juvenile Idiopathic Arthritis), leading to unnecessary procedures and treatments. The objective of the current study was to identify the molecular basis in a family with PPRD and describe their phenotype and course of illness. Patients and methods We present here a multiply affected consanguineous family of Iraqi-Jewish descent with PPRD. The proband, a 6.5 years old girl, presented with bilateral symmetric bony enlargements of the 1st interphalangeal joints of the hands, without signs of synovitis. Molecular analysis of the family was pursued using Whole Exome Sequencing (WES) and homozygosity mapping. Results WES analysis brought to the identification of a novel homozygous missense mutation (c.257G > T, p.C86F) in the WISP3 gene. Following this diagnosis, an additional 53 years old affected family member was found to harbor the mutation. Two other individuals in the family were reported to have had similar involvement however both had died of unrelated causes. Conclusion The reported family underscores the importance of recognition of this unique skeletal dysplasia by clinicians, and especially by pediatric rheumatologists and orthopedic surgeons.http://link.springer.com/article/10.1186/s12881-019-0787-xWISP3CCN6Progressive pseudorheumatoid dysplasiaPPRDPseudorheumatoid arthritis of childhood
spellingShingle Ben Pode-Shakked
Asaf Vivante
Ortal Barel
Shai Padeh
Dina Marek-Yagel
Alvit Veber
Shachar Abudi
Aviva Eliyahu
Irit Tirosh
Shiri Shpilman
Shirlee Shril
Friedhelm Hildebrandt
Mordechai Shohat
Yair Anikster
Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
BMC Medical Genetics
WISP3
CCN6
Progressive pseudorheumatoid dysplasia
PPRD
Pseudorheumatoid arthritis of childhood
title Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
title_full Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
title_fullStr Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
title_full_unstemmed Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
title_short Progressive Pseudorheumatoid Dysplasia resolved by whole exome sequencing: a novel mutation in WISP3 and review of the literature
title_sort progressive pseudorheumatoid dysplasia resolved by whole exome sequencing a novel mutation in wisp3 and review of the literature
topic WISP3
CCN6
Progressive pseudorheumatoid dysplasia
PPRD
Pseudorheumatoid arthritis of childhood
url http://link.springer.com/article/10.1186/s12881-019-0787-x
work_keys_str_mv AT benpodeshakked progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT asafvivante progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT ortalbarel progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT shaipadeh progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT dinamarekyagel progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT alvitveber progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT shacharabudi progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT avivaeliyahu progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT irittirosh progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT shirishpilman progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT shirleeshril progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT friedhelmhildebrandt progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT mordechaishohat progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature
AT yairanikster progressivepseudorheumatoiddysplasiaresolvedbywholeexomesequencinganovelmutationinwisp3andreviewoftheliterature